Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT01265030
Principal Investigator:
A Prospective Phase III Study of Patients with Newly Diagnosed Very Low-risk and Low-risk Fusion Negative Rhabdomyosarcoma
Study Type: Treatment
Phase: III
NCTID: NCT05304585
Principal Investigator:
Keith August
A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma
Study Type: Treatment
Phase: III
NCTID: NCT05235165
Principal Investigator:
Keith August
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide VAC Alternating with Vincristine and Irinotecan VI versus VAC/VI plus Temsirolimus TORI, Torisel, NSC 683864 in Patients with Intermediate Risk IR Rhabdomyosarcoma RMS
Study Type: Treatment
Phase: III
NCTID: NCT02567435
Principal Investigator:
Keith August
A Phase I/II Open-Label Trial of CPI-613� devimistat plus Hydroxychloroquine to Evaluate Maximally Tolerated Dose MTD, Safety and Efficacy in Patients with Relapsed or Refractory Clear Cell Sarcoma CCS
Study Type: Treatment
Phase: I/II
NCTID: NCT04593758
Principal Investigator:
Benjamin Powers
A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High Risk Retroperitoneal Sarcoma STRASS2
Study Type: Treatment
Phase: III
NCTID: NCT04031677
Principal Investigator:
Luke Selby
Single Person IND for the Use of TK216 in a patient with metastatic Ewing sarcoma
Study Type: Treatment
Phase: N/A
NCTID: NCT00000000
Principal Investigator:
Benjamin Powers
A Phase 2 Study of DS-8201a NSC 807708 in Adolescents, or Young Adults with Recurrent HER2+ Osteosarcoma
Study Type: Treatment
Phase: II
NCTID: NCT04616560
Principal Investigator:
Kevin Ginn
A Phase III, Multicentre, Randomised, Double-Blind Study to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Subjects with Tenosynovial Giant Cell Tumour
Study Type: Treatment
Phase: III
NCTID: NCT05417789
Principal Investigator:
Benjamin Powers
A Phase II Study of Belinostat and SGI-110 Guadecitabine for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
Study Type: Treatment
Phase: II
NCTID: NCT04340843
Principal Investigator:
Benjamin Powers